SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-007468
Filing Date
2024-05-09
Accepted
2024-05-09 07:30:11
Documents
14
Period of Report
2024-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240508x8k.htm   iXBRL 8-K 45616
  Complete submission text file 0001558370-24-007468.txt   174703

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20240508.xsd EX-101.SCH 4155
3 EX-101.DEF chrs-20240508_def.xml EX-101.DEF 3156
4 EX-101.LAB chrs-20240508_lab.xml EX-101.LAB 15905
5 EX-101.PRE chrs-20240508_pre.xml EX-101.PRE 10733
17 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240508x8k_htm.xml XML 4855
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 24928580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)